Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma-Reference-Cited by-同舟云学术

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma

Published:2022-12 Issue: Volume: Page:103638
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Inada Makoto,Togano Tomiteru,Terada Mari,Shiratori Katsuyuki,Tsuzuki Shinya,Takamatsu Yuki,Saito Sho,Hangaishi Akira,Morioka Shinichiro,Kutsuna Satoshi,Maeda Kenji,Mitsuya Hiroaki,Ohmagari Norio

Funder

Japan Agency for Medical Research and Development

National Center for Global Health and Medicine

Government of Japan Ministry of Health Labour and Welfare

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow;Garraud;Transfus Clin Biol,2016

2. SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from national center for global health and medicine;Hayakawa;Glob Health Med,2020

3. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial;Li;JAMA,2020

4. How we secured a COVID-19 convalescent plasma procurement scheme in Japan;Terada;Transfusion,2021

5. Activities of coagulation factors in fresh frozen plasma after long-term storage;Fuchizaki;Jpn J Transfus Cell Ther,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of a Bead-Based Multiplex Assay for SARS-CoV-2 Antibody Detection;Biology;2024-04-18

2. Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals;Life;2023-11-09